Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

Revista de la Federacion Argentina de Cardiologia is a vital publication in the field of Cardiology and Cardiovascular Medicine, providing a platform for researchers and healthcare professionals to share significant findings and innovative concepts since its inception in 2012. Published by the Federacion Argentina Cardiology, this journal specifically addresses contemporary issues and advancements within cardiology, contributing to the scholarly dialogue essential for improving cardiovascular health. Despite being categorized in the Q4 quartile for 2023 and presently ranking #358 out of 387 in its field, the journal remains committed to fostering academic inquiry and disseminating valuable research for both local and global audiences. Although it is not an open-access journal, it strives to balance accessibility with rigorous academic standards, ensuring quality contributions that are critical for practitioners and students alike. The journal’s ongoing evaluation and adaptation in the ever-evolving landscape of cardiology underscore its importance in advancing cardiovascular science and practice.

The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.

BASIC RESEARCH IN CARDIOLOGY, published by SPRINGER HEIDELBERG, is an esteemed peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine since 1973. With a strong emphasis on the latest breakthroughs in basic and translational research, this journal offers a platform for high-quality, impactful studies that contribute to our understanding of cardiac function and related physiological processes. Currently ranked in the Q1 category in Cardiology and Cardiovascular Medicine, as well as Physiology and Medical Physiology, BASIC RESEARCH IN CARDIOLOGY is recognized as a leading journal within these disciplines, boasting impressive Scopus ranks that place it in the top tiers of global research output. While it does not offer open access, its contributions are pivotal for researchers, clinicians, and students seeking to stay abreast of cutting-edge discoveries and methodologies in cardiovascular science. With its commitment to scholarly excellence, this journal plays a critical role in shaping the future of cardiac research and clinical practice.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

The Monaldi Archives for Chest Disease, published by PAGEPRESS PUBL, is a vital resource for researchers and healthcare professionals dedicated to the fields of cardiology and pulmonary medicine. With an ISSN of 1122-0643 and an E-ISSN of 2532-5264, this Open Access journal has been committed to disseminating high-quality research since 2004, ensuring that findings in chest disease are easily accessible to a global audience. Based in Italy, the journal features contributions that reflect a broad scope of topics within its fields, achieving a Q3 ranking in both Cardiology and Cardiovascular Medicine, as well as in Pulmonary and Respiratory Medicine as of 2023. The journal's Scopus ranks place it at 168th out of 387 in its cardiology category and 83rd out of 155 in pulmonary medicine, indicating its relevance in the academic landscape. With its commitment to advancing knowledge and practice, the Monaldi Archives for Chest Disease stands as an essential platform for publication and dialogue in chest disease research, appealing to a diverse audience of scholars and practitioners.

CLINICAL SCIENCE, published by PORTLAND PRESS LTD, is a prestigious journal with an established history that dates back to 1946. Renowned for its rigorous peer-reviewed articles, the journal is dedicated to advancing knowledge in the field of medicine, particularly in the nuances of clinical science and translational research. With an impressive Q1 ranking in the **Medicine (miscellaneous)** category and a Scopus rank of #32 out of 636 in general medicine, it is firmly positioned in the top 5% percentile of its field, making it an essential resource for researchers, practitioners, and students aiming to stay at the forefront of the discipline. Although the journal operates on a traditional subscription model, its influence and accessibility ensure that critical findings and innovative methodologies reach a wide audience, fostering collaboration and progress within the global medical community. The journal seeks to publish groundbreaking studies, critical reviews, and insights that can translate into improved clinical practices, thus reinforcing its mission to enhance patient care and medical knowledge.

Current Treatment Options in Cardiovascular Medicine is a leading journal dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by SpringerNature, this journal seeks to bridge the gap between clinical practice and research by providing comprehensive reviews, insightful analyses, and updates on the latest treatment modalities available for cardiovascular diseases. With an ISSN of 1092-8464 and an E-ISSN of 1534-3189, it displays a commitment to disseminating critical information to healthcare professionals and researchers globally. Despite its recent categorization in the Q3 quartile, the journal continues to maintain relevance with a Scopus rank of #246 in the field, reflecting its contribution to the ongoing discourse in cardiovascular care. The publication encompasses a broad spectrum of topics, from interventional cardiology to pharmacotherapy, supporting the journal's objective to enhance patient care through evidence-based treatment options. Researchers, professionals, and students will find Current Treatment Options in Cardiovascular Medicine an indispensable resource for staying at the forefront of cardiovascular innovations and applications.

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

Rational Pharmacotherapy in Cardiology, published by the SOC CARDIOLOGY RUSSIAN FEDERATION, stands as a crucial platform for advancing knowledge in the field of cardiology and pharmacology. Established as an Open Access journal in 2005, it allows for unrestricted access to research findings, fostering collaboration among researchers, clinicians, and students. The journal, with its ISSN 1819-6446 and E-ISSN 2225-3653, focuses on the intersection of rational pharmacotherapy and cardiovascular medicine, aiming to enhance treatment strategies and patient outcomes through evidence-based studies. Though currently positioned in the Q4 category in both cardiology and pharmacology rankings, its ongoing commitment to rigorous peer review and scholarly research ensures its relevance and growth in the scientific community. With a unique address in Moscow, Russia, the journal seeks to serve as a valuable resource for those dedicated to improving cardiovascular health and therapeutic practices worldwide, making it an essential read for professionals keen on the latest trends and discoveries in this vital area of medicine.